Cite
HARVARD Citation
Amin, A. et al. (2014). Estimated medical cost reductions associated with use of novel oral anticoagulants vs warfarin in a real-world non-valvular atrial fibrillation patient population. Journal of medical economics. pp. 771-781. [Online].